JACOB MORRILL: Open Payments
NPI 1770184434 · NORFOLK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,214 in 56 payments from 14 companies in 2025. Trend: 2023 $942 · 2024 $1,244 · 2025 $1,214
Food & beverage: $1,163Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $379 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $179 |
| Janssen Biotech, Inc. | 5 | $132 |
| Ipsen Biopharmaceuticals, Inc | 5 | $120 |
| Madrigal Pharmaceuticals | 3 | $62 |
| Aimmune Therapeutics, Inc. | 2 | $58 |
| Ardelyx, Inc. | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| STERIS CORPORATION | 1 | $43 |
| Phathom Pharmaceuticals, Inc. | 5 | $41 |
Products named: RINVOQ, ENTYVIO, TREMFYA, IQIRVO, SKYRIZI, REZDIFFRA, ZENPEP, LINZESS.
Industry payments across NE — which companies pay providers there.
